Forschung
The Risk of Ocular Adverse Events after Anti-PD-1/PD-L1 Antibodies is Dose-independent: A Preliminary Report of a Prospective Observation
Maho Sato, Hirohisa Kubono, Kazuya Yamashita, Takashi Nagamoto, Yoshiko Ofuji, Ryuki Fukumoto, Hideko Akagi, Mari Kawamura, Kotaro Suzuki